Business Standard

Sunday, January 19, 2025 | 12:20 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid-19: Pune study shows seroprevalence of antibodies in 51.5% samples

A serological survey is done to detect the presence of specific antibodies, and is used to assess the prevalence of a disease in the population

Coronavirus, Coronavirus tests
Premium

A healthcare worker wearing Personal Protective Equipment (PPE) collects a sample using a swab from a man to conduct tests for Coronavirus diseases (COVID-19) amid the spread of the disease in New Delhi on Friday.

Press Trust of India Pune
Pune's first sero survey has found that 51.5 per cent of the 1644 respondents from five highly- affected wards in the city have seroprevalence of antibodies against SARS-CoV-2, the virus which causes Covid-19 infection.

A serological survey is done to detect the presence of specific antibodies, and is used to assess the prevalence of a disease in the population.

Data from the Pune sero survey was released on Monday. The survey had 1,664 respondents (all above 18 years) from the city's five wards whose population is 366,000.

The survey was conducted by the Indian Institute of Science Education and Research

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in